Pages that link to "Q46120766"

The following pages link to Serum-soluble interleukin-2 receptors in neuroleptic-naive schizophrenic subjects and in medicated schizophrenic subjects with and without tardive dyskinesia (Q46120766):

Displaying 43 items.

• Cytokines in Schizophrenia: Hope or Hype? (Q26750430) (← links)
• Meta-analysis of cytokine alterations in schizophrenia: clinical status and antipsychotic effects (Q28657600) (← links)
• Soluble cytokine receptors (sIL-2Rα, sIL-2Rβ) induce subunit-specific behavioral responses and accumulate in the cerebral cortex and basal forebrain (Q28730302) (← links)
• Effects of antipsychotic drugs on cytokine networks (Q34133802) (← links)
• Differentiating primary pathophysiologic from secondary adaptational processes (Q34415542) (← links)
• Immunological research in clinical psychiatry: report on the consensus debate during the 7th Expert Meeting on Psychiatry and Immunology (Q34886325) (← links)
• Immunity and schizophrenia: autoimmunity, cytokines, and immune responses (Q35032959) (← links)
• Inflammation and schizophrenia (Q36870045) (← links)
• Schizophrenia as a systemic disease (Q37137037) (← links)
• Serial mitogen-stimulated cytokine production from continuously ill patients with schizophrenia (Q37479996) (← links)
• Vitamin D in schizophrenia: a clinical review (Q38696598) (← links)
• Interleukin-2 modulates N-methyl-D-aspartate receptors of native mesolimbic neurons (Q43543771) (← links)
• Interleukin-2 potentiates novelty- and GBR 12909-induced exploratory activity (Q43581337) (← links)
• Interleukin-2-induced increases in climbing behavior: inhibition by dopamine D-1 and D-2 receptor antagonists (Q44054458) (← links)
• HLA-DRB1 association with schizophrenia in Saudi Arabian patients (Q44874150) (← links)
• An association between increased serum-soluble interleukin-2 receptors and a disturbance in muscle force in schizophrenic patients (Q45989045) (← links)
• CSF IL-1 and IL-2 in medicated schizophrenic patients and normal volunteers. (Q45996585) (← links)
• Lower serum cytokine levels in smokers than nonsmokers with chronic schizophrenia on long-term treatment with antipsychotics (Q46416824) (← links)
• Protein-C reactive as biomarker predictor of schizophrenia phases of illness? A systematic review. (Q47553108) (← links)
• Persistently increased serum soluble interleukin-2 receptors in continuously ill patients with schizophrenia (Q48009432) (← links)
• A meta-analysis of blood cytokine network alterations in psychiatric patients: comparisons between schizophrenia, bipolar disorder and depression (Q48063321) (← links)
• Elevated plasma levels of S-100b protein in schizophrenic patients (Q48193822) (← links)
• Interleukin-2 and -6 induce behavioral-activating effects in mice (Q48356606) (← links)
• Schizophrenia and other mental disorders require long-term adoptive immunotherapy (Q48495270) (← links)
• Hypercytokinemia-induced metabolic encephalopathy in a multiple myeloma patient on hemodialysis undergoing autologous stem cell transplantation: clinical response after plasma exchange. (Q48563583) (← links)
• Modulation of behavioral and neurochemical measures of forebrain dopamine function in mice by species-specific interleukin-2. (Q48791270) (← links)
• Production of interferon-gamma in families with multiple occurrence of schizophrenia (Q50966629) (← links)
• Investigations of cytokine production in whole blood cultures of paranoid and residual schizophrenic patients (Q51000957) (← links)
• Elevated interleukin-2, interleukin-6 and interleukin-8 serum levels in neuroleptic-free schizophrenia: association with psychopathology (Q51953367) (← links)
• Plasma levels of cytokines and soluble cytokine receptors in psychiatric patients upon hospital admission: effects of confounding factors and diagnosis (Q51981236) (← links)
• Polymorphism of CTLA-4 gene at position 49 of exon 1 may be associated with schizophrenia in the Korean population (Q56904446) (← links)
• Cytokine profiles in drug-naive schizophrenic patients (Q57997579) (← links)
• A Meta-analysis of Immune Parameters, Variability, and Assessment of Modal Distribution in Psychosis and Test of the Immune Subgroup Hypothesis (Q58589435) (← links)
• Soluble interleukin 2 receptor levels in families of people with schizophrenia (Q59791822) (← links)
• Genes for interleukin-2 receptor beta chain, interleukin-1 beta, and schizophrenia: no evidence for the association or linkage (Q73418008) (← links)
• Decreased in vitro production of interferon-gamma and interleukin-2 in whole blood of patients with schizophrenia during treatment (Q73816366) (← links)
• Brain and ventricle instability during psychotic episodes of the schizophrenias (Q73924945) (← links)
• Immunophenotypic studies on atypical lymphocytes in psychiatric patients (Q74440856) (← links)
• Activation of indices of cell-mediated immunity in bipolar mania (Q77935206) (← links)
• [Cytokine network in patients with schizophrenia and its significance for the pathophysiology of the illness] (Q79777536) (← links)
• Association between TNF-α promoter −308A/G polymorphism and tardive dyskinesiain Chinese Han patients with schizophrenia (Q83193460) (← links)
• Association Study of the Complement Component C4 Gene in Tardive Dyskinesia (Q92069771) (← links)
• (Q95427748) (← links)